Human C-C Chemokine Receptor Type 5

<strong>Human C-C Chemokine Receptor Type 5</strong>_x000D_ <strong>Catalog number:</strong> B2016509_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> N/A_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> N/A_x000D_ <strong>Keywords:</strong> CD195, CC-CKR-5, CKR5, CMKBR5_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, Gangadaran P, Ahn BC. Tumor microenvironment signaling and therapeutics in cancer progression Cancer Commun (Lond). 2023 May;43(5):525-561._x000D_ 2: Feng G, Bajpai G, Ma P, Koenig A, Bredemeyer A, Lokshina I, Lai L, Förster I, Leuschner F, Kreisel D, Lavine KJ. CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells Circulation. 2022 Mar 8;145(10):765-782._x000D_ 3: Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, Chen X, Zhang B, Liang H, Liu D, Feng Y, Wang Y, Li Y, Liu B, Huang W, Xia L. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2 J Hepatol. 2023 Jul;79(1):109-125._x000D_ 4: Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: An evolving chemokine Cytokine. 2022 May;153:155828._x000D_ 5: Hamilton JD, Harel S, Swanson BN, Brian W, Chen Z, Rice MS, Amin N, Ardeleanu M, Radin A, Shumel B, Ruddy M, Patel N, Pirozzi G, Mannent L, Graham NMH. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases Clin Exp Allergy. 2021 Jul;51(7):915-931._x000D_ 6: Tian L, Xu B, Chen Y, Li Z, Wang J, Zhang J, Ma R, Cao S, Hu W, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity Nat Cancer. 2022 Nov;3(11):1318-1335._x000D_ 7: Park JH, Lee DH, Park MS, Jung YS, Hong JT. C-C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation J Gastroenterol Hepatol. 2017 Jun;32(6):1258-1264._x000D_ 8: Tanaka T, Suzuki H, Li G, Nanamiya R, Isoda Y, Okada Y, Kobayashi H, Yoshikawa T, Kaneko MK, Kato Y. Epitope Mapping of the Anti-Human CC Chemokine Receptor Type-2 Monoclonal Antibody (K036C2) Monoclon Antib Immunodiagn Immunother. 2022 Oct;41(5):285-289._x000D_ 9: Festa BP, Siddiqi FH, Jimenez-Sanchez M, Rubinsztein DC. Microglial cytokines poison neuronal autophagy via CCR5, a druggable target Autophagy. 2024 Apr;20(4):949-951._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33932468">10: Kim J, Lee J, Kim HJ, Kameyama N, Nazarian R, Der E, Cohen S, Guttman-Yassky E, Putterman C, Krueger JG. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets J Allergy Clin Immunol. 2021 Nov;148(5):1281-1292. </a>_x000D_ _x000D_ <strong>Products Related to Human C-C Chemokine Receptor Type 5 can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>